Rigel Pharmaceuticals, Inc. - RIGL

About Gravity Analytica
Recent News
- 03.10.2025 - Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors
- 03.10.2025 - Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors
- 03.04.2025 - Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
- 03.04.2025 - Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
- 02.25.2025 - Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update
- 02.25.2025 - Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update
Recent Filings
- 03.10.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.10.2025 - 3 Initial statement of beneficial ownership of securities
- 03.10.2025 - 8-K Current report
- 03.04.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
- 03.04.2025 - EX-99.1 EX-99.1
- 03.04.2025 - 8-K Current report
- 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 02.11.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 02.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 02.06.2025 - 4 Statement of changes in beneficial ownership of securities